Marché du traitement du psoriasis par technologie, part, demande, croissance, opportunité, analyse de projection Perspectives prévisionnelles 2028

Une nouvelle étude de marché, intitulée « Psoriasis Treatment Market Forecast 2021-2028 » a été présentée sur Fortune Business Insights™.

 

*** Obtenez le dernier rapport d’étude de marché mis à jour avec  un exemple de rapport gratuit

Aperçu du marché:

La taille du marché mondial du traitement du psoriasis devrait atteindre 40,58 milliards de dollars d’ici la fin de 2027. L’accent accru mis sur le développement de produits biologiques pour le traitement du psoriasis contribuera à la croissance du marché global dans les années à venir. Selon un rapport publié par Fortune Business Insights, intitulé « Taille du marché du traitement du psoriasis, analyse de la part et de l’impact de Covid-19, par classe de médicament (inhibiteurs du TNF, interleukines et autres), par type (plaque psoriasis, polyarthrite psoriasique et autres) , par voie d’administration (orale, parentérale/systémique et topique) par canal de distribution (pharmacies hospitalières, pharmacies de détail et pharmacies en ligne) et prévisions régionales, 2020-2027 », le marché valait 20,09 milliards USD en 2019 et présentent un TCAC de 9,2% au cours de la période de prévision, 2020-2027.

Demande d’échantillon gratuit de rapport PDF @  www.fortunebusinessinsights.com/enquiry/sample/psoriasis-treatment

Le marché ne sera pas affecté par la pandémie de Covid-19 en cours

La récente épidémie de coronavirus a remis en question les performances de divers secteurs d’activité à travers le monde. Plusieurs débats sont menés ; en ce qui concerne l’effet de l’épidémie et les prévisions sont établies à un rythme rapide. Malgré la gravité de la pandémie, il est peu probable que cette épidémie restreigne les performances des entreprises du marché du traitement du psoriasis.

Un nombre croissant d’approbations réglementaires émergera en faveur de la croissance du marché

The report encompasses several factors that have contributed to the growth of the overall psoriasis treatment market in recent years. Among all factors, the increasing number of regulatory usage approvals by leading organizations such as the Food and Drug Administration has had the highest impact on the growth of the market. The report highlights a few of the major FDA approvals of recent times and discusses their impact on the growth of the overall market. In April 2019, Ortho Dermatologics announced that it has received approval from the FDA for a lotion in treatment of patients suffering from psoriasis. The company received approval for use of ‘Duobrii’ for treatment of plaque psoriasis. The product will be used in adults suffering from plaque psoriasis. Several efforts are being made for the development of newer products, in tandem with Duobrii for the treatment of other serious psoriasis conditions.

North America to Emerge Dominant; Increasing Prevalence of Psoriasis will Aid Growth

The report analyses the latest market trends across five major regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among all regions, the market in North America is projected to emerge dominant in the coming years. The increasing prevalence of psoriasis and several conditions associated with this disease. The growing demand for novel treatment options for this disease will aid the growth of the regional market. As of 2019, the market in North America was worth 8.48 billion and this value is projected to increase at a considerable pace in the coming years. The market in Asia Pacific is projected to exhibit the highest CAGR in the coming years driven by the presence of several large scale companies in several countries across this region.

List of companies profiled in the report:

  • AbbVie Inc. (Illinois, United States)
  • Novartis AG (Basel, Switzerland)
  • Johnson & Johnson Services, Inc. (New Jersey, United States)
  • Pfizer Inc., (New York, United States)
  • LEO Pharma A/S (Ballerup, Denmark)
  • Merck & Co., Inc. (New Jersey, United States)
  • Amgen Inc. (California, United States)
  • Eli Lilly and Company (Indiana, United States)
  • CELGENE CORPORATION (New Jersey, United States)
  • UCB S.A. (Brussels, Belgium)
  • Sun Pharmaceutical Industries Ltd. (Mumbai, India)
  • Other prominent players

Speak To Analyst @ www.fortunebusinessinsights.com/enquiry/speak-to-analyst/psoriasis-treatment-market-100600

NOTE : Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. We aim to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: [email protected]

LinkedIn: https://www.linkedin.com/company/fortune-business-insights

Facebook: https://www.facebook.com/FortuneBusinessInsightsPvtLtd

Twitter :  https://twitter.com/FBInsightPvtLtd